
CAS 10161-87-2
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produits concernés.
Benzoic acid, 4-[4-[(2-bromoacetyl)amino]butyl]-
CAS :Formule :C13H16BrNO3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :314.17504-(4-(2-Bromoacetamido)butyl)benzoic acid
CAS :4-(4-(2-Bromoacetamido)butyl)benzoic acidDegré de pureté :98%Masse moléculaire :314.18g/molKRA-533
CAS :KRA-533 is an effective KRAS agonist that targets the GTP/GDP binding pocket within the KRAS protein, inhibiting GTP cleavage.Formule :C13H16BrNO3Degré de pureté :98.11%Couleur et forme :SolidMasse moléculaire :314.18Ref: TM-T38411
2mg42,00€5mg62,00€10mg95,00€25mg194,00€50mg334,00€100mg560,00€200mg798,00€1mL*10mM (DMSO)69,00€4-{4-[(Bromoacetyl)amino]butyl}benzoic acid
CAS :4-{4-[(Bromoacetyl)amino]butyl}benzoic acid is a ligand that binds to Ion channels. 4-{4-[(Bromoacetyl)amino]butyl}benzoic acid is a bidentate ligand, which interacts with the extracellular loops of the receptor. This compound has been shown to activate both potassium and chloride ion channels. 4-{4-[(Bromoacetyl)amino]butyl}benzoic acid has also been shown to inhibit the activity of beta adrenergic receptors, leading to hypotension and bradycardia in animals. 4-{4-[(Bromoacetyl)amino]butyl}benzoic acid is a high purity research tool that can be used for studying protein interactions, peptides, antibodies, cell biology and pharmacology.
Formule :C13H16BrNO3Degré de pureté :Min. 95%Masse moléculaire :314.17 g/mol



